GRYPHIRA Trademark

Trademark Overview


On Tuesday, March 16, 2021, a trademark application was filed for GRYPHIRA with the United States Patent and Trademark Office. The USPTO has given the GRYPHIRA trademark a serial number of 79310429. The federal status of this trademark filing is REGISTERED as of Tuesday, November 2, 2021. This trademark is owned by NOVARTIS AG. The GRYPHIRA trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the p...
gryphira

General Information


Serial Number79310429
Word MarkGRYPHIRA
Filing DateTuesday, March 16, 2021
Status700 - REGISTERED
Status DateTuesday, November 2, 2021
Registration Number6541782
Registration DateTuesday, November 2, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 17, 2021

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 12, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Sunday, May 15, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, April 25, 2022FINAL DISPOSITION NOTICE SENT TO IB
Monday, April 25, 2022FINAL DISPOSITION PROCESSED
Wednesday, February 2, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 2, 2021REGISTERED-PRINCIPAL REGISTER
Sunday, August 29, 2021NOTIFICATION PROCESSED BY IB
Tuesday, August 17, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 17, 2021PUBLISHED FOR OPPOSITION
Wednesday, August 4, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 4, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, July 28, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, July 24, 2021REFUSAL PROCESSED BY IB
Monday, July 12, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 12, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 12, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 12, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 9, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, July 9, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 9, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, July 9, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 9, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 9, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, June 26, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, June 25, 2021REFUSAL PROCESSED BY MPU
Friday, June 18, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, June 17, 2021NON-FINAL ACTION WRITTEN
Sunday, June 6, 2021CORRECTION TRANSACTION RECEIVED FROM IB
Wednesday, June 2, 2021ASSIGNED TO EXAMINER
Thursday, May 27, 2021ASSIGNED TO EXAMINER
Tuesday, May 18, 2021APPLICATION FILING RECEIPT MAILED
Wednesday, May 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, May 11, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Saturday, May 8, 2021SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB